Primary Hyperoxaluria Type 3

Explore clinical trials studying Primary Hyperoxaluria Type 3. Study availability and eligibility vary by location and protocol.

5 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Primary Hyperoxaluria Type 3 trial results

Not Yet Recruiting

NCT06465472

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +16 more
Locations: Not specified

Completed

NCT05001269

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +17 more
Locations: Clinical Research Site Rochester, Minnesota, United States

Clinical Research Site Hamilton, Ontario, Canada

Clinical Trial Site Bonn, Germany

Clinical Research Site Heidelberg, Germany

View all 13 locations

Completed

NCT04542590

Conditions: Calcinosis, Calcium Metabolism Disorders, Calculi, +22 more
Locations: Clinical Trial Site Boston, Massachusetts, United States

Clinical Trial Site New York, United States

Clinical Trial Site Toronto, Ontario, Canada

Clinical Trial Site Heidelberg, Germany

Completed

NCT04555486

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +12 more
Locations: Clinical Trial Site Boston, Massachusetts, United States

Clinical Trial Site Rochester, Minnesota, United States

Clinical Trial Site New York, United States

Clinical Trial Site Bonn, Germany

Active, Not Recruiting

NCT03655223

Conditions: 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations: RTI International Research Triangle Park, North Carolina, United States